drugset / Trial / NCT05336825

CO2 Laser vs Lidocaine for Vestibulodynia in Premenopausal Women

NCT05336825 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

CO2 laser energy is currently used widely for the treatment of postmenopausal women who have vaginal atrophy due to the lack of estrogen. However, its effect on premenopausal women with hormonally-mediated vulvar vestibulodynia is unknown. This study seeks to evaluate the effect of CO2 laser on young women and compare it to topical lidocaine.

Timeline

Start
2019-04-01
Primary completion
2021-01-31
Completion
2021-01-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 5 % Topical

Indications